ACQUISITIONS AND DIVESTITURES - Purchase Price Allocations (Details) - USD ($) $ in Thousands	Dec. 30, 2023	Nov. 30, 2023	Jan. 27, 2023	Dec. 31, 2022	Apr. 05, 2022	Jun. 28, 2021	Mar. 30, 2021	Mar. 29, 2021	Dec. 31, 2020
Business Acquisition [Line Items]
Inventories			$ 0		$ 0
Goodwill	$ 3,095,045			$ 2,849,903
Redeemable noncontrolling interest			0		0
Noveprim Group
Business Acquisition [Line Items]
Noncontrolling ownership interest	10.00%
Noveprim Group
Business Acquisition [Line Items]
Trade receivables		$ 1,308
Inventories		66,500
Other current assets (excluding cash)		3,965
Property, plant and equipment		35,831
Operating lease right-of-use asset, net		104
Goodwill		172,349
Definite-lived intangible assets		9,500
Other long-term assets		167,907
Deferred revenue		0
Other current liabilities		(16,378)
Operating lease right-of-use liabilities (Long-term)		(97)
Deferred tax liabilities		(12,984)
Other long-term liabilities		(7,797)
Redeemable noncontrolling interest		(45,374)
Total purchase price allocation		374,834
Biological assets		$ 167,800
Biological assets, useful life		8 years
SAMDI Tech, Inc.
Business Acquisition [Line Items]
Trade receivables			513
Other current assets (excluding cash)			75
Property, plant and equipment			593
Operating lease right-of-use asset, net			0
Goodwill			37,129
Definite-lived intangible assets			33,070
Other long-term assets			6
Deferred revenue			(43)
Other current liabilities			(351)
Operating lease right-of-use liabilities (Long-term)			0
Deferred tax liabilities			(8,191)
Other long-term liabilities			0
Total purchase price allocation			$ 62,801
Explore BioLabs
Business Acquisition [Line Items]
Trade receivables					7,679
Other current assets (excluding cash)					1,067
Property, plant and equipment					37,369
Operating lease right-of-use asset, net					48,613
Goodwill					215,752
Definite-lived intangible assets					70,100
Other long-term assets					556
Deferred revenue					(3,507)
Other current liabilities					(15,507)
Operating lease right-of-use liabilities (Long-term)					(57,193)
Deferred tax liabilities					(18,601)
Other long-term liabilities					(1,807)
Total purchase price allocation					284,521
Goodwill resulting from transaction					$ 5,000
Vigene
Business Acquisition [Line Items]
Trade receivables						$ 3,548
Other current assets (excluding cash)						1,657
Property, plant and equipment						7,649
Operating lease right-of-use asset, net						22,507
Goodwill						239,681
Definite-lived intangible assets						93,900
Other long-term assets						694
Deferred revenue						(4,260)
Other current liabilities						(6,319)
Operating lease right-of-use liabilities (Long-term)						(21,220)
Deferred tax liabilities						(13,958)
Total purchase price allocation						$ 323,879
Retrogenix
Business Acquisition [Line Items]
Trade receivables							$ 2,266
Other current assets (excluding cash)							209
Property, plant and equipment							400
Operating lease right-of-use asset, net							1,385
Goodwill							34,489
Definite-lived intangible assets							22,126
Other long-term assets							0
Deferred revenue							(434)
Other current liabilities							(1,141)
Operating lease right-of-use liabilities (Long-term)							(1,205)
Deferred tax liabilities							(4,174)
Total purchase price allocation							$ 53,921
Cognate
Business Acquisition [Line Items]
Trade receivables								$ 18,566
Other current assets (excluding cash)								14,128
Property, plant and equipment								52,082
Operating lease right-of-use asset, net								34,349
Goodwill								611,555
Definite-lived intangible assets								270,900
Other long-term assets								6,098
Deferred revenue								(20,539)
Other current liabilities								(45,388)
Operating lease right-of-use liabilities (Long-term)								(31,383)
Deferred tax liabilities								(32,503)
Total purchase price allocation								877,865
Estimated tax liability								$ 17,000
Distributed Bio
Business Acquisition [Line Items]
Trade receivables									$ 2,722
Other current assets (excluding cash)									221
Property, plant and equipment									2,382
Operating lease right-of-use asset, net									1,586
Goodwill									71,585
Definite-lived intangible assets									24,540
Other long-term assets									469
Deferred revenue									(1,319)
Other current liabilities									(1,504)
Operating lease right-of-use liabilities (Long-term)									(1,123)
Deferred tax liabilities									(2,529)
Total purchase price allocation									$ 97,030